The blood test will help to check the immunity of vaccinated people

Metropolis Healthcare has launched COVIPROTECT, a blood test, which helps to measure the immunity status of a person vaccinated with the COVID-19 vaccine. The new and upgraded quantitative test will help to understand seroprevalence in a community and determine the possibility of past infection.

The sensitive and specific antibody assay detects IgG type of antibodies to S1 & S2 subunits of spike proteins of SARS-CoV-2. COVIPROTECT is Conformité Européenne (CE) marked and is approved by the US Food and Drug Administration (FDA) EUA.

Nilesh Shah, Group President, Metropolis Healthcare, “This test is not mandatory but helps people understand if they have responded to the vaccine and if they have developed enough antibodies.”

The test is available across the company’s network in India. It is recommended to take the test three to four weeks after natural infection and two weeks after the second dose of the vaccine. The reports will be generated within 24 hours.